Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial

Lee, Jeeyun; Hoon Lim, Do; Kim, Sung; Hoon Park, Se; Oh Park, Joon; Suk Park, Young; Yeong Lim, Ho; Gew Choi, Min; Sung Sohn, Tae; Hyung Noh, Jae; Moon Bae, Jae; Chan Ahn, Yong; Sohn, Insuk; Ho Jung, Sin; Keun Park, Cheol; Kim, Kyoung‐Mee; Ki Kang, Won

doi:10.1200/jco.2011.39.1953

Public

Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial

Published in Journal of Clinical Oncology • Dec 19, 2011

Authors:

Jeeyun Lee

Do Hoon Lim

Sung Kim

Abstract

PURPOSE: The ARTIST (Adjuvant Chemoradiation Therapy in Stomach Cancer) trial was the first study to our knowledge to investigate the role of postoperative chemoradiotherapy therapy in patients with curatively resected gastric cancer with D2 lymph node dissection. This trial was designed to compare ...

Subject

Capecitabine

Medicine

Radiation therapy

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!